Literature DB >> 2429017

[Intraductal chemotherapy of bile duct cancer with 5-fluorouracil].

H J Schmeck, E Bartels, C H Viets, W Arnold.   

Abstract

The prognosis of bile duct cancer is still poor. Curative surgical therapy is possible in only 10%-20% of cases. Palliative effects of chemotherapy and radiation are small. Newer palliative techniques like iridium 192 wire radiation or hepatic artery infusion of chemotherapeutic agents seem to be more effective. Another new form of palliative local chemotherapy, intrabiliary application of 5-fluorouracil, is described. A 67-year-old woman with an adenocarcinoma of the left and common hepatic ducts received symptomatic therapy by an external biliary drainage for 20 months. In the following 3 weeks the amount of drained bile diminished and finally stopped, while icterus occurred. Catheter cholangiography showed a right catheter position, the known obstruction of the common hepatic duct and the left bile duct, and a diffuse right-sided peripheral bile duct occlusion, regarded as multifocal tumor spreading. Intraductal application of 5-fluorouracil via the PTCD tube, 125-375 mg twice a week, effected a rising bile secretion after a few days, to a final volume of 1,000 ml/day. An X-ray control 34 days after start of the therapy showed a nearly complete reopening of the formerly occluded peripheral bile duct system and a filiform reopening of the common hepatic duct with sufficient flowing off into the common bile duct and the duodenum. Certain side effects of this therapy were not noticed. After successful reopening of malignant bile tract occlusion, other palliative therapeutic techniques like internal bile drainage or iridium 192 wire radiation can be applied.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429017     DOI: 10.1007/bf01712057

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  10 in total

Review 1.  Mitomycin C: a review.

Authors:  S T Crooke; W T Bradner
Journal:  Cancer Treat Rev       Date:  1976-09       Impact factor: 12.111

2.  Biliary drainage.

Authors:  M Classen; F Hagenmüller
Journal:  Endoscopy       Date:  1983-05       Impact factor: 10.093

Review 3.  The management of proximal biliary tract tumors.

Authors:  P J Broe; J L Cameron
Journal:  Adv Surg       Date:  1981

4.  [Endoscopic intraductal radiotherapy of high bile-duct carcinoma].

Authors:  J Phillip; F Hagenmüller; K Manegold; S Szepesi; M Classen
Journal:  Dtsch Med Wochenschr       Date:  1984-03-16       Impact factor: 0.628

Review 5.  The role of radiation therapy in cancer of the extra-hepatic biliary system: an analysis of thirteen patients and a review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy.

Authors:  G Kopelson; L Harisiadis; P Tretter; C H Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Sep-Oct       Impact factor: 7.038

6.  Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer.

Authors:  Y Sasaki; S Imaoka; Y Hasegawa; S Nakano; O Ishikawa; H Ohigashi; K Taniguchi; H Koyama; T Iwanaga; T Terasawa
Journal:  Cancer       Date:  1985-01-15       Impact factor: 6.860

7.  Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma.

Authors:  G W Smith; R M Bukowski; J S Hewlett; C W Groppe
Journal:  Cancer       Date:  1984-10-15       Impact factor: 6.860

8.  Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer.

Authors:  G Falkson; J M MacIntyre; C G Moertel
Journal:  Cancer       Date:  1984-09-15       Impact factor: 6.860

9.  [Intrabiliary tract administration of adriamycin in bile duct cancer].

Authors:  I Mizuno; F Tanada; A Iwai; F Kato; J Yura
Journal:  Gan To Kagaku Ryoho       Date:  1982-04

10.  Radiotherapy of high bile duct carcinoma using intra-catheter iridium 192 wire.

Authors:  F Mornex; J M Ardiet; P Bret; J P Gerard
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.